Patient Guides: ESMO Patient Guides Compilation (Belgium): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 21: | Line 21: | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">Head</span> | |||
<span style="display:none">Neck</span> | |||
<span style="display:none">Oral</span> | |||
<span style="display:none">Oral cavity</span> | |||
<span style="display:none">Pharynx</span> | |||
<span style="display:none">Pharyngeal</span> | |||
<span style="display:none">Tongue</span> | |||
<span style="display:none">Lingual</span> | |||
<span style="display:none">Nasal cavity</span> | |||
<span style="display:none">Nasal</span> | |||
<span style="display:none">Sinonasal</span> | |||
<span style="display:none">Sinus</span> | |||
<span style="display:none">Sinuses</span> | |||
<span style="display:none">Paranasal sinuses</span> | |||
<span style="display:none">Ear</span> | |||
<span style="display:none">Mandible</span> | |||
<span style="display:none">Maxilla</span> | |||
<span style="display:none">Jaw</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Subcutaneous</span> | |||
<span style="display:none">Extremity</span> | |||
<span style="display:none">Peripheral nerve</span> | |||
<span style="display:none">Skeletal</span> | |||
<span style="display:none">Osseous</span> | |||
<span style="display:none">Chondral</span> | |||
<span style="display:none">Ocular</span> | |||
<span style="display:none">Orbital</span> | |||
<span style="display:none">Retinal</span> | |||
<span style="display:none">Optic nerve</span> | |||
<span style="display:none">Meninges</span> | |||
<span style="display:none">Meningeal</span> | |||
<span style="display:none">Cerebral</span> | |||
<span style="display:none">Cerebellar</span> | |||
<span style="display:none">Brainstem</span> | |||
<span style="display:none">Lymphatic</span> | |||
<span style="display:none">Lymphoid</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Hematologic</span> | |||
<span style="display:none">Hematopoietic</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
Latest revision as of 12:07, 14 December 2025
Go back to Belgium page
Primary purpose: To translate complex medical language into understandable information for patients. Click here to learn more.
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. Click here to learn more.
Cancer areas of interest: C40-C41: Bone cancers; C15-C26: Digestive system cancers; C51-C58: Female genitalia cancer; C81-C96: Cancers of the blood and immune system; C69-C72: Eye and brain cancer; C00-C14: Mouth/throat cancers; C45-C49: Soft tissue cancer. Side Effects of Immunotherapy and Its Management; AML; Bone Sarcomas; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancers; CML; Stomach Cancer; Soft Tissue Sarcomas. Click here to learn more.
Access to information: Click here to access.